Tokyo, Sept. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063077) titled 'Stratified, randomized, double-blind, crossover trial on the cognitive function-enhancing effects of dextrin intake' on Sept. 28.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Glico Nutrition Co., Ltd.
Condition:
Condition - Healthy men and women
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the effects of ingesting highly branched cyclic dextrin which is broken down and absorbed relatively slowly on cognitive function.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Duration: 1 day
Test product: Beverage containing highly branched cyclic dextrin
Interventions/Control_2 - Duration: 1 day
Test product: glucose-containing drink
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Healthy, right-handed men and women aged 18 to 29
Key exclusion criteria - 1 Individuals with mental disorders or sleep disorders
2 Individuals with visual impairments
3 Individuals with motor impairments of the fingers or hands
4 Individuals with diabetes or abnormal glucose metabolism
5 Individuals using medications that affect blood glucose levels
6 Smokers
7 Left handed individuals
Target Size - 24
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 08 Month 25 Day
Date of IRB - 2026 Year 08 Month 25 Day
Anticipated trial start date - 2026 Year 10 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072210
Disclaimer: Curated by HT Syndication.
